Endothelium-Derived Neuregulin Protects the Heart Against Ischemic Injury
Open Access
- 24 May 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 123 (20), 2254-2262
- https://doi.org/10.1161/circulationaha.110.991125
Abstract
Background—: Removal of cardiac endothelial cells (EC) has been shown to produce significant detrimental effects on the function of adjacent cardiac myocytes, suggesting that EC play a critical role in autocrine/paracrine regulation of the heart. Despite this important observation, the mediators of the protective function of EC remain obscure. Neuregulin (NRG, a member of the epidermal growth factor family) is produced by EC and cardiac myocytes contain receptors (erbB) for this ligand. We hypothesized that NRG is an essential factor produced by EC, which promotes cardioprotection against ischemic injury. Methods and Results—: We demonstrate that human cardiac EC express and release NRG in response to hypoxia–reoxygenation. Under conditions where hypoxia–reoxygenation causes significant cardiac myocyte cell death, NRG can significantly decrease apoptosis of isolated adult ventricular myocytes. Coculturing adult murine myocytes with human umbilical vein, murine lung microvascular, or human coronary artery EC can also protect myocytes against hypoxia–reoxygenation–induced apoptosis. These protective effects are abolished by NRG gene deletion or silencing of NRG expression in EC. Finally, endothelium-selective deletion of NRG in vivo leads to significantly decreased tolerance to ischemic insult, as demonstrated by impaired postischemic contractile recovery in a perfused whole-organ preparation and larger infarct sizes after coronary artery ligation. Conclusion—: Together, these data demonstrate that EC-derived NRG plays an important role in cardiac myocyte protection against ischemic injury in the heart and supports the idea that manipulation of this signaling pathway may be an important clinical target in this setting.This publication has 33 references indexed in Scilit:
- Metalloproteinase‐dependent cleavage of neuregulin and autocrine stimulation of vascular endothelial cellsThe FASEB Journal, 2010
- The Vulnerability of the Heart As a Pluricellular Paracrine OrganCirculation Research, 2010
- Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusionJCI Insight, 2009
- Neuregulin-1β Is Associated With Disease Severity and Adverse Outcomes in Chronic Heart FailureCirculation, 2009
- Ectodomain cleavage of the EGF ligands HB‐EGF, neuregulin1‐β, and TGF‐α is specifically triggered by different stimuli and involves different PKC isoenzymesThe FASEB Journal, 2008
- VE‐cadherin‐CreERT2 transgenic mouse: A model for inducible recombination in the endotheliumDevelopmental Dynamics, 2006
- Role of Neuregulin-1/ErbB2 Signaling in Endothelium-Cardiomyocyte Cross-talkOnline Journal of Public Health Informatics, 2006
- Neuregulin-1α and β isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitroExperimental Cell Research, 2005
- Dilated cardiomyopathy in Erb-b4-deficient ventricular muscleAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Patterning of Muscle Acetylcholine Receptor Gene Expression in the Absence of Motor InnervationNeuron, 2001